Aileron Therapeutics (ALRN) Q3 2023 Earnings

13OctConfirmed
Nov 22
Q1 2023
Q2 2023
Q3 2023
-1.65
-1.23
-0.81
-0.39

Details

Expected EPS
N/A
Actual EPS
-0.4
Surprise EPS
-0.4
Surprise Percent
+∞%

Description

Aileron Therapeutics (ALRN) has reported earnings of -0.4 per share for Q3 2023.

0 Comments

Share your thoughts